Search

everythinglearnresearchcommunity

for

Search:↓

Autoimmune diseases with high tissue recovery often relapse and remit, while those with low recovery rarely remit.

A woman's rare scalp condition worsened after using a specific arthritis medication, suggesting such medications can sometimes trigger or aggravate psoriasis.

A girl with Becker naevus syndrome has a genetic variant in the ACTB gene related to her symptoms.

P2X₃-IR fibers are widespread in rat skin and likely help detect pain.

Researchers found a new mutation in the HR gene causing hair loss and skin bumps in a Pakistani family.

A 5 cm hair sample can reveal blood type and keratin type for forensic use.

A man with hypoparathyroidism had other health issues that led to a diagnosis of a rare autoimmune disorder, APS-1.

Inflammasome proteins may help diagnose and treat Parkinson's disease.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Talquetamab may cause hair loss and skin issues.

PDRN may reduce inflammation and complications in revision rhinoplasty for patients with high fibrinogen levels.

Erosive pustular dermatosis of the scalp can occur about 17 weeks after starting EGFR inhibitors, and early minocycline may help manage it.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Adalimumab may cause severe hair loss in some patients.

PLD is an effective and safer alternative for treating breast cancer.

A liver transplant patient with APECED had a rare VZV recurrence and pneumonia, treated successfully, but later died from other infections.

The p.P25L mutation in the KRT5 gene causes a rare skin condition that worsens over time and may lead to hair loss starting in young adulthood.

Certolizumab effectively treats psoriasis and psoriatic arthritis with fewer side effects than adalimumab.

Malondialdehyde-modified DNA may trigger an immune response in alopecia areata patients.

C4BPA protein may link acne severity and insulin resistance.

Calprotectin levels are higher in alopecia areata patients, indicating systemic inflammation.

Low PON1 levels may indicate and predict the severity of hair loss.

Hair dye may trigger anti-GBM disease relapse, and rituximab can help manage it.

Belimumab effectively controls SLE disease activity and reduces steroid use.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Immunological skin diseases in pigs are rare and can be caused by immune system issues or external factors.

People with no symptoms or mild COVID-19 have lower antibody levels, increasing their risk of getting COVID-19 again.